V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210031423 | 210013498 | 1.69 | 69 | Disease modification (D) | 2017-01-15 | 2017-02-05 | Inotuzumab Ozogamicin | 2 | N | 210041053 | IDELALISIB |
| 210031424 | 210013506 | 0 | 58.6 | Curative (C) | 2016-07-24 | 2016-07-24 | IDELALISIB | 2 | N | 210041101 | CHLORAMBUCIL + OFATUMUMAB |
| 210031425 | 210013508 | 1.74 | 13.7 | Disease modification (D) | 2017-06-14 | 2017-07-25 | UKALL XII Induction Phase 1 | N | N | 210041106 | RIALTO TRIAL |
| 210031426 | 210013511 | 0 | 14.4 | Adjuvant (A) | 2016-03-02 | 2016-04-21 | Bevacizumab 15mg/kg | N | N | 210041115 | IDELALISIB |
| 210031427 | 210013512 | 1.7 | 96.1 | Disease modification (D) | 2015-03-04 | 2015-03-14 | CNS GCT II Germinoma - Carbo Etop | N | N | 210041122 | PONATINIB |
| 210031428 | 210022464 | 0 | 84.8 | Palliative (P) | 2012-11-29 | 2013-07-16 | Dasatinib | N | N | 210041181 | DASATINIB |
| 210031429 | 210013518 | null | null | Palliative (P) | 2014-12-04 | 2017-08-26 | IDELALISIB | N | N | 210041191 | METHOTREXATE HIGH DOSE |
| 210031430 | 210013521 | 1.75 | 25.5 | Curative (C) | null | 2017-12-21 | Dasatinib | Y | N | 210041193 | DASATINIB |
| 210031431 | 210013526 | 1.73 | 85.2 | Curative (C) | 2018-08-22 | 2018-08-22 | CHOP | 02 | N | 210041199 | METHOTREXATE HIGH DOSE |
| 210031432 | 210013531 | 1.77 | 105 | Curative (C) | null | 2013-12-11 | Cyclophosphamide + Vincristine | N | N | 210041244 | PENTOSTATIN |
| 210031434 | 210013534 | 1.68 | 11.5 | Palliative (P) | 2016-11-25 | 2017-04-08 | LOMUSTINE + PROCARBAZINE | N | N | 210041263 | LOMUSTINE + PROCARBAZINE |
| 210031435 | 210013539 | null | 95 | null | 2016-03-06 | 2016-03-13 | RIALTO TRIAL | N | N | 210041279 | RIALTO TRIAL |
| 210031436 | 210013546 | 1.52 | 61.1 | Disease modification (D) | 2015-09-11 | 2015-09-17 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 210041346 | CARBOPLATIN + VINCRISTINE |
| 210031437 | 210022475 | 1.67 | 69 | Curative (C) | 2016-04-16 | 2016-06-01 | Cyclophosphamide + Vincristine | N | N | 210041357 | RIALTO TRIAL |
| 210031438 | 210013557 | null | 83.9 | Curative (C) | 2018-01-18 | 2018-09-17 | Erwinase (Erwinia Asparaginase) | N | N | 210041403 | BENDAMUSTINE |
| 210031439 | 210013560 | 1.7 | 79.6 | Disease modification (D) | 2017-03-11 | 2017-10-19 | Inotuzumab Ozogamicin | N | N | 210041408 | NELARABINE |
| 210031440 | 210013561 | 1.77 | null | Curative (C) | 2014-06-11 | 2014-06-11 | CLADRIBINE | N | null | 210041423 | CLADRIBINE |
| 210031441 | 210028097 | null | 32.9 | Curative (C) | 2016-05-01 | 2016-05-09 | CVP R | N | N | 210041452 | PONATINIB |
| 210031442 | 210013566 | null | null | null | 2015-09-07 | 2015-11-07 | CNS Low Grade Glioma Vinblastine | N | N | 210041459 | VINBLASTINE |
| 210031443 | 210022485 | 0 | 63.6 | Curative (C) | null | 2015-01-10 | Vinblastine weekly | N | N | 210041488 | VINBLASTINE |
| 210031444 | 210013577 | 1.8 | 72.8 | Curative (C) | 2014-07-01 | 2014-07-04 | Procarbazine | 02 | N | 210041526 | PROCARBAZINE |
| 210031445 | 210013579 | 1.51 | 55 | Palliative (P) | 2019-06-03 | 2019-06-03 | LOMUSTINE + PROCARBAZINE | 02 | N | 210041546 | LOMUSTINE + PROCARBAZINE |
| 210031446 | 210013587 | 1.51 | 55 | Curative (C) | 2014-12-31 | 2014-12-31 | CHLORAMBUCIL + OFATUMUMAB | 02 | null | 210041577 | INOTUZUMAB OZOGAMICIN |
| 210031447 | 210038806 | 1.54 | 63 | Palliative (P) | null | 2018-02-27 | Docetaxel 75mg/m2 (21 day) | N | N | 210041599 | BEVACIZUMAB + IRINOTECAN |
| 210031448 | 210037863 | 1.77 | 83.7 | Palliative (P) | 2013-11-04 | 2013-11-04 | BOSUTINIB | N | N | 210041615 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 210031449 | 210013589 | 1.69 | null | Adjuvant (A) | null | 2016-09-21 | PNET 4 HIT-SIOP Maintenance | N | Y | 210041618 | CISPLATIN |
| 210031450 | 210013592 | 1.76 | 98.2 | Palliative (P) | 2019-03-10 | 2019-07-25 | Brentuximab | 2 | N | 210041621 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE |
| 210031451 | 210013596 | 0 | 53 | Adjuvant (A) | null | 2015-06-05 | Hydroxycarbamide | 02 | N | 210041630 | CISPLATIN |
| 210031452 | 210033677 | 1.63 | 35.5 | Curative (C) | 2018-04-26 | 2018-04-28 | Lenalidomide 25mg (Cycle 1 to 25) | N | null | 210041643 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE |
| 210031453 | 210013605 | 1.67 | 98.8 | Adjuvant (A) | null | 2017-03-18 | PENTOSTATIN + RITUXIMAB | N | N | 210041679 | METHOTREXATE + VINCRISTINE |
| 210031454 | 210013608 | 0 | null | null | 2018-07-16 | 2018-09-12 | Erlotinib | N | Y | 210041701 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210031455 | 210033679 | 0 | null | Curative (C) | 2018-02-11 | 2018-02-11 | CVP | N | N | 210041746 | PACLITAXEL |
| 210031456 | 210013614 | 1.6 | null | Curative (C) | null | 2014-01-21 | BR14 TRIAL | Y | N | 210041789 | LENVATINIB |
| 210031457 | 210013615 | 1.5 | 69.3 | Curative (C) | 2014-06-05 | 2014-07-24 | CYTARABINE + ETOPOSIDE | Y | N | 210041797 | CODOX M |
| 210031458 | 210013617 | 1.81 | 84.4 | Curative (C) | 2018-06-17 | 2018-06-24 | CLARITY Trial | N | null | 210041810 | PACKER MAINTENANCE |
| 210031459 | 210013621 | null | 80.5 | Curative (C) | 2019-05-15 | 2019-05-15 | Gemcitabine + Oxaliplatin | N | N | 210041817 | TAVAREC TRIAL |
| 210031460 | 210013625 | null | null | Curative (C) | null | 2017-01-11 | Nilotinib | Y | N | 210041820 | IRINOTECAN + TEMOZOLOMIDE |
| 210031461 | 210013628 | 1.68 | 35 | Curative (C) | 2015-09-19 | 2015-10-16 | Cytarabine HD + Methotrexate HD | N | N | 210041854 | ERLOTINIB |
| 210031462 | 210013631 | 1.69 | 74 | Curative (C) | 2015-11-08 | 2016-02-02 | Bevacizumab + Irinotecan | Y | N | 210041861 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 210031463 | 210022515 | 1.73 | null | Curative (C) | 2015-04-16 | 2015-04-21 | Lenalidomide 15mg (Cycle 1 to 25) | N | N | 210041872 | BEVACIZUMAB + LOMUSTINE |
| 210031464 | 210013636 | 1.7 | 72.9 | Curative (C) | 2018-06-19 | 2018-06-19 | Fludarabine oral | Y | N | 210041902 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 210031465 | 210013641 | 1.92 | null | Curative (C) | null | 2015-07-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE | N | N | 210041947 | GEMCARBO |
| 210031466 | 210013644 | 1.72 | null | Curative (C) | 2017-11-01 | 2018-02-20 | CLL210 TRIAL | Y | N | 210041983 | NILOTINIB |
| 210031467 | 210013647 | 0 | 133 | Curative (C) | 2017-03-06 | 2017-03-06 | Cisplatin chemoembolisation | N | null | 210042028 | CARBO + ETOPOSIDE + VINCRISTINE |
| 210031468 | 210013648 | 1.54 | 78.8 | Palliative (P) | 2015-04-27 | 2015-05-02 | CNS HGG HERBY Maint Temoz+Bev | Y | N | 210042033 | DOCETAXEL |
| 210031469 | 210022525 | 1.75 | null | Curative (C) | 2016-07-19 | 2016-07-25 | LOMUSTINE + PROCARBAZINE + VINCRISTINE | N | N | 210042045 | TRASTUZUMAB EMTANSINE |
| 210031470 | 210013652 | 1.08 | 38.1 | Curative (C) | 2014-05-05 | 2014-05-05 | Docetaxel + Nintedanib | null | N | 210042048 | BEVACIZUMAB + LOMUSTINE |
| 210031471 | 210022528 | 1.72 | 53 | Curative (C) | 2015-03-13 | 2015-04-26 | FLAG | N | N | 210042059 | REGORAFENIB |
| 210031472 | 210013656 | 1.62 | null | Curative (C) | 2017-07-17 | 2017-07-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE | Y | N | 210042061 | FLAG |
| 210031473 | 210013657 | 1.65 | 0 | Curative (C) | 2015-06-14 | 2015-06-14 | Hydroxycarbamide | N | N | 210042066 | BRENTUXIMAB |